Addressing the Opioid Crisis: A Look at the Evolving Landscape of Federal OUD Treatment Policies July 11, 2023 Issue Brief Federal policies governing substance use disorder treatment have undergone rapid changes during the pandemic; however, the extent to which these changes can address the surge in opioid overdose deaths is unclear. Some of these policy adjustments are permanent, while others could revert to pre-pandemic regulations. In this brief, we examine the following 5 key federal policies and implications for access and treatment for OUD.
A Small Number of Drugs Account for a Large Share of Medicare Part D Spending July 12, 2023 Issue Brief The Inflation Reduction Act requires the federal government to negotiate the price of certain high-spending drugs covered by Medicare. This analysis provides context for understanding the potential impact of negotiating prices for a limited number of Medicare-covered drugs by identifying the 10 top-selling Part D drugs in 2021, measuring the share of total Part D drug spending accounted for by top-selling drugs that year, and examining changes in spending and use of these drugs since 2018.
A Closer Look at the Five Largest Publicly Traded Companies Operating Medicaid Managed Care Plans July 6, 2023 Issue Brief This brief takes a closer look at the five largest publicly traded companies operating Medicaid MCOs which account for half of Medicaid MCO enrollment nationally. Information and data reported in this brief come from quarterly company earnings reports, financial filings, and other company materials as well as from national administrative data.
The Title X Network Has Largely Returned Under the Biden Administration May 25, 2023 News Release A new KFF brief examines the return of grantees and clinic sites to the Title X network under the Biden Administration, which reversed Trump Administration regulations that prohibited Title X sites from providing abortion referrals and having co-located abortion services. For more than 50 years, the federal Title X program…
Rebuilding the Title X Network Under the Biden Administration May 25, 2023 Issue Brief This issue brief examines what has happened to the Title X network under the Biden Administration regulations, including the number of clinics that have returned to the network, new funding, and how state policies that prohibit pregnancy options counseling that includes abortion and referrals may impact grantees’ participation in the Title X program.
Employment Among Immigrants and Implications for Health and Health Care June 12, 2023 Issue Brief This brief examines socioeconomic characteristics and employment patterns among immigrant workers and examines how they compare to U.S.-born workers, including differences among college-educated workers.
Health Care Disparities Among Asian, Native Hawaiian, and Other Pacific Islander (NHOPI) People May 24, 2023 Issue Brief In this data note, we use 2019 American Community Survey (ACS) data to examine how demographic characteristics as well as measures of health coverage and other social and economic factors that drive health and health care vary for Asian and NHOPI people overall and by subgroups.
Breaking Down the U.S. Global Health Budget by Program Area April 18, 2023 Fact Sheet The U.S. government is the largest donor to global health in the world. This fact sheet breaks down the U.S. global health budget by program area: HIV/PEPFAR; tuberculosis; malaria/the President’s Malaria Initiative; the Global Fund to Fight AIDS, Tuberculosis, and Malaria; maternal & child health; nutrition; family planning & reproductive health; global health security; and neglected tropical diseases.
Ending the Public Health Emergency for Medicaid Home- and Community-Based Services April 19, 2023 Blog This policy watch explores the potential implications of ending the PHE for Medicaid HCBS programs.
Who Uses Telecontraception and Why? A Closer Look at Clients of Four Telecontraception Companies April 4, 2023 Issue Brief Based on the findings of a nonprobability sample of 6,000 survey respondents from four telecontraception companies, this brief presents a snapshot of telecontraception users and their reasons for using these platforms.